Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
Clinical trial NCT05638295 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05638295
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2028-12-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.